Immunomodulation by platelet-derived DKK1: potential for controlling disease and pathology in leishmaniasis and implications for other infectious diseases - Top-Institutions - MDSpire

Immunomodulation by platelet-derived DKK1: potential for controlling disease and pathology in leishmaniasis and implications for other infectious diseases

  • By

  • Olivia C. Ihedioha

  • Diane McMahon-Pratt

  • Alfred L. M. Bothwell

  • June 2, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Nebraska Medical Center
    University of Nebraska Medical Center

    Omaha, Nebraska

    Key Differentiators

    • Infectious Disease
    • Immunology

  • #2

    Yale University
    Yale University

    New Haven, Connecticut

    Key Differentiators

    • Infectious Disease
    • Public Health

  • #3

    AP-HP Saint-Louis Hospital
    AP-HP Saint-Louis Hospital

    Paris, France

    Key Differentiators

    • Infectious Disease

  • #4

    European Collection of Cell Cultures
    European Collection of Cell Cultures

    Salisbury, United Kingdom

    Key Differentiators

    • Cell Culture
    • Immunology

  • #5

    University Hospital of Bologna
    University Hospital of Bologna

    Bologna, Italy

    Key Differentiators

    • Infectious Disease
    • Transplantation

Original Source(s)

Immunomodulation by platelet-derived DKK1: potential for controlling disease and pathology in leishmaniasis and implications for other infectious diseases

  • by Olivia C. Ihedioha, Diane McMahon-Pratt, Alfred L. M. Bothwell

  • June 2, 2026

Related Content

Pyroptosis-immunity-microbiome axis in acute upper gastrointestinal bleeding: mechanisms, risk prediction, and individualized strategies

The Sm29 antigen differentially shapes transcriptomic and regulatory landscapes across reactional forms of leprosy

Internet Searches for Vitamin A and Related Media Statements During the 2025 US Measles Outbreak